A Phase 1 Study Evaluating the Safety, Tolerability and Efficacy of AMG 119 in Subjects With RR SCLC

Name: A Phase 1 Study Evaluating the Safety, Tolerability and Efficacy of AMG 119 in Subjects With RR SCLC
License: Public Domain

Amgen

ClinicalTrials.gov · Datasets · License: Public Domain

small cell lung cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 172302
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.